behrns cv 8-9-16 - university of florida · kevin e. behrns, m.d. august 9, 2016 curriculum vitae...

Curriculum Vitae Name: Kevin E. Behrns Home Address: 10707 SW 27th Avenue Gainesville, FL 32608 Phone: (352) 375-7187 Date and Place of Birth: October 30, 1958 Wabasha, MN Marital Status: Married; 3 Children Education: University of St. Thomas, St. Paul, MN Bachelor of Arts, Summa Cum Laude, May 1983 Physical Education Mayo Medical School, Rochester, MN Medical Doctor, May 1988 Mayo Graduate School of Medicine General Surgery Resident, 1988-1990, 1993-1995 Clinical Investigator, Department of Surgery, 1991-1992 Employment History: Mayo Graduate School of Medicine General Surgery Resident 1988 to 1995 University of North Carolina at Chapel Hill, Department of Surgery Assistant Professor of Surgery (July 1, 1995 to August 31, 2000) Associate Professor of Surgery (September 1, 2000 to June 30, 2005) University of Florida, Department of Surgery Robert H. Hux Professor of Surgery (November 5, 2005 – June 30, 2008) Vice Chairman of Surgery (July 1, 2005 – June 30, 2008) Chief of General Surgery (July 1, 2005 – July 31, 2010) Program Director (July 1, 2006 – June 30, 2009) Interim Chairman (July 1, 2008 – July 23, 2009) Edward R. Woodward Professor (September 15, 2008 – present) Chairman (July 24, 2009 – present) Certificate/Licensure: State of North Carolina Board of Medical Examiners Medicine and Surgery Licensure, No. 95-00508 State of Florida Board of Medical Examiners, MFC No. 1578 American Board of Surgery December 10, 1996, Recertification December 2005, 2011 Certificate No. 41844

Kevin E. Behrns, M.D. August 9, 2016

Curriculum Vitae –

Active Society Memberships: American Association for the Study of Liver Diseases

American Board of Plastic Surgery Director, 2013-2017 Bylaws and Publications Committee Credentials and Requrirements Committee Ethics Committee American Board of Surgery

Director, 2011-2017 Qualifying Examination Committee, 2007-present

Chair, 2014-present Credentials Committee, 2013-present Gastrointestinal Surgery Advisory Council, 2014-present

American College of Surgeons Fellow Web Portal GI Surgery Community Editor

Committee on Applicants, 2009-2012 American College of Surgeons Board of Governors, 2009-2015

Executive Committee Board of Governors, 2014-2016 Member Services Pillar Chair, 2014-present Committee on Socioeconomic Issues Surgical Volunteerism & Humanitarian Award Workgroup

Chair, 2013-2014 American College of Surgeons, Florida Chapter Executive Council, 2009-present

American Gastroenterologic Association American Hepato-Pancreato-Biliary Association

Publications committee, 2005 Membership committee, 2006 Co-chair Publications committee, 2007-2008 American Surgical Association Halsted Society Secretary-Treasurer Elect, 2014

Secretary-Treasurer, 2015-2017 International Society of Surgery (ISS), 2016-present

Pancreas Club Program Committee, 2004 The Priestley Society Councilor, 2004-2007 Society of Surgery of the Alimentary Tract Ad Hoc Abstract Review, 1999-2000

Program Committee, 2001-2003 Publications Committee, 2008-present Nominating Committee, 2009 Board of Trustees, 2004-2010 Advanced GI Training Task Force Intersocietal Committee on Advanced GI Surgery Training, 2016-present Vice President, 2016-2017

Society of Surgical Chairs Councilor-at-Large

Society of University Surgeons



Southeastern Surgical Congress First Vice President

CME Committee Council Member Finance Committee

Southern Surgical Association Local Arrangements Chair, 2010 2nd Vice President, 2011 Surgeons Travel Club President, 2014 Surgical Biology Club II

Woodward Society

Past Society Memberships: American Association for the Advancement of Science Alachua County Medical Society

American Medical Association Association for Academic Surgery Committee on Issues, 2000

Executive Committee member, 1999-2002 American Pancreatic Association

Eastern Surgical Society Local Arrangements, Co-Chair, 2013

Nathan Womack Surgical Society North Carolina Chapter, American College of Surgeons

Society of American Gastroenterological Endoscopy and Surgery Professional Service: Co-Editor in Chief, Surgery, 2015-present

Editor in Chief: The Year Book of Surgery, 2012-present Editor/Associate Editor: GI Section of the Year Book of Surgery, 2011-2012 Editorial Board: Surgery, Journal of Surgical Research, American College of Surgeons Web Portal GI Surgery Community Editor, Journal of Gastrointestinal Surgery, World Journal of Gastroenterology, American Journal of Surgery, HPB, Journal of the American College of Surgeons Reviewer for: The American Surgeon, American Journal of Physiology, Hepatology, Archives of Internal Medicine, Mayo Clinic Proceedings, Medical Crossfire, Gastroenterology, Southern Medical Journal, Journal of the American College of Surgeons, Annals of Surgery, World Journal of Surgery, Cancer Research UK, American Journal of Surgery, Cytokine, Annals of Surgical Oncology, Free Radicals in Biology and Medicine, Molecular Carcinogenesis, FEBS Letters, Stem Cells and Development, European Surgical Research, NHS Greater Glasgow & Clyde Health Board (UK),Liver International

Associate Examiner: American Board of Surgeons Certifying Examinations Consultant: American Board of Surgery Qualifying Examination Question Writing Committee Special Emphasis Panel Member/Grant Reviewer: NIH/NCI Cellular & Tissue Oncology P01; ZDK1 GRB-7 (J2)



Grants Funded: Current Support

NIH/NIDDK: Autophagy in Liver Injury 7/1/14-8/31/19 (PI: Kim) $321,331 (current year funding) UF Cancer & Aging Grant: Mitochondrial dysfunction by chemotherapy agents in aged livers 1/2/1 –12/31/16 (Co-PI: J-S Kim) $60,000 (current year funding)

Past Support University of North Carolina, Junior Faculty Development Award, 1995.

University of North Carolina, University Research Council, 1995.

Center for Gastrointestinal Biology and Disease Pilot Feasibility Award, 1996.

National Institutes of Health, Mentored Clinical Scientist Development Award (K08), Growth Control of Normal and Cirrhotic Hepatocytes, 1999-04.

American Digestive Health Foundation, Industry Research Scholar Award, Mechanisms of Apoptosis Resistance in Hepatocytes, 1999-02.

National Institutes of Health, Small Grant Program for K08 Recipients (R03), Growth Control of Normal and Cirrhotic Hepatocytes, 2002-04.

National Institutes of Health, National Cancer Institute, SPORE in Gastrointestinal Cancer: Mechanisms of Apoptosis Resistance in Hepatocellular Carcinoma, Career Development Award, 8/1/04 – 7/31/05.

University of North Carolina, University Research Council, 2004. Ruth L. Kirschstein NRSA Institutional Research Training Grant: Surgical Oncology Research Training; 9/28/05-8/31/10 (PI: Behrns) NIH/NIDDK – ARRA; Growth Control of Normal and Cirrhotic Hepatocytes 2/5/10 – 1/31/2011 (PI: Behrns) NIH/NIDDK: Growth Control of Normal and Cirrhotic Hepatocytes 10/1/05-8/31/11 (PI: Behrns) NIH/NIGMS: Molecular Biology and Gene Therapy in Burns and Trauma 7/1/14-6/30/19 (PI: Moldawer) (Behrns: Mentor) Ruth L. Kirschstein NRSA Institutional Research Training Grant: Surgical Oncology Research Training; 09/01/2010-06/30/2015 (PI: Behrns)

Clinical Trials: Behrns KE. Co-Investigator. A double-blind, randomized, placebo-controlled multi-center trial to evaluate the efficacy and safety of two doses of Lexipafant for the treatment of acute pancreatitis. IND# 48612, British Biotech.

Behrns KE. Investigator. A randomized, double-blind, placebo-controlled, multi-center phase III study of intravenous Betafectin PGG-Glucan for the prevention of serious infection in patients undergoing upper gastrointestinal surgery who are at high risk for infection. Protocol F-G97-01, Alpha-Beta Technology, Inc.



Behrns, KE. Investigator. An open-label, large simple usual care study of the effect of adding Rofecoxib 50 mg to a regimen of selected opiod analgesic prn in patients undergoing selected outpatient surgical procedures. Protocol 03-Surg-487, Merck & Co., Inc.

Continuing Education: Teaching Scholars Program, 1997-1999

Program for Chiefs of Clinical Services, Harvard School of Public Health, 2010 Courses Taught GMS 6381: Special Topics in Pathology: Cellular & Molecular Basis of Liver Disease,

University of Florida, 2008, 2009 Administrative Activities Administrative Chief Resident, 1994-1995 & Committees: co-Director, Center for Pancreatic and Biliary Diseases, 1999 Chief, Division of Gastrointestinal Surgery 2004-2005 Chief, Division of General Surgery, 2005-2010 Vice Chairman, Department of Surgery Associate Program Director, 2005-2006 Program Director, 2006-2009 Medical Director Surgical Clinics, 2005-2007 Chair, SUF OR Policy Committee SUF Task Force Resident Positions, 2005-present Collaborator Mentor, Molecular Oncology & Drug Discovery Program, UF Shands Cancer Center/Moffitt Cancer Center, 2010-present Internal Advisory Committee, UF Shands Cancer Center, 2010-present

Surgical Research Committee, Member Surgical Education Committee, Member

Resident Education Committee, Member Tissue Advisory Committee, Member

Department of Surgery Clinical Practice Committee, Member Center for Gastrointestinal Biology & Disease, Full Member

OR Users Committee, Member PACS Committee, Member Student Appeals Committee, Member Executive Committee Department of Surgery Executive Education Committee Department of Surgery, Chair Career Development Committee, Vice-Chair Florida Group Practice, Executive Medical Director Committee Search Committee Obstetrics & Gynecology Chair, 2007 Search Committee Dermatology Chair, 2010 Search Committee Anesthesiology Chair, 2013-2014 Shands/UF Surgical OR Policy Committee, Member College of Medicine Executive Committee College of Medicine Faculty Compensation Committee,

Chair, 2013-present Shands Teaching Hospital & Clinics, Inc, Board of Directors Member, 2009-present Shands/UF Board Quality Committee Chair, 2013-present Shands/UF Medical Staff Quality & Operations Committee Shands/UF Perioperative Governance Committee Shands/UF Surgical Safety Initiative Committee University of Florida Physicians Payor Committee Shands/UF Surgical Safety Initiative Co-chair Shands/UF Professional Credentials Committee



Shands/UF Strategic Planning Committee Shands/UF Health Hospital Planning Steering Committee, 2013-present College of Medicine LCME Sub-Committee on Governance Chair, 2014-2015 UF Health Capital Review Advisory Committee, 2015-present UF Health, Power of Together Implementation Team: Data & Analytics, 2015-present Medical Director Operating Room, 2015-present

Special Honors and Awards: Nygaard Research Travel Award, 1994 Gray Clinical Travel Award, 1995 Resident Teacher of the Year, 1995 Teacher of the Year, 1997 Pearls Day Speaker, 1999 Alpha Omega Alpha Honor Society, 1999 Teaching Scholar, 1999 James IV Association Traveling Fellowship, 2002 Teaching Scholar, 2002 Anthony A. Meyer Mentor of the Year Award, 2003 Lester R. Dragstedt Physician-Scientist Award, 2007, 2012

Edward M. Copeland Faculty Award, 2009, 2013 Original Publications: Refereed: 1. Behrns KE, Soper NJ, Sarr MG, Kelly, Hughes RW. Anatomic, motor, and clinical assessment of vertical banded

gastroplasty. Gastroenterology, 1989;97:91-97.

2. Behrns KE, van Heerden JA. Surgical management of hepatic hydatid disease. Mayo Clin Proc, 1991;66:1193-1197.

3. Prabhakar LP, Herkes SM, Smith CD, Behrns KE, Sarr MG. Effects of duodenal flow on interdigestive patterns of small bowel myoelectric activity. J Gastrointestinal Motility,1992; 4:71-76.

4. Sarr MG, Behrns KE, van Heerden JA. Total pancreatectomy. An objective analysis of its use in pancreatic cancer. Hepatogastroenterology, 1993;40:418-421.

5. Smith CD, Herkes SM, Behrns KE, Fairbanks VF, Sarr MG. Gastric acid secretion and vitamin B12 absorption after vertical Roux-en-Y gastric bypass for morbid obesity. Ann Surg, 1993;218:91-96

6. Behrns KE, Smith CD, Kelly KA, Sarr MG. Reoperative bariatric surgery. Lessons learned to improve patient selection and results. Ann Surg, 1993;218:646-653.

7. Nemanich M, Behrns KE, Sarr MG. Motilin, erythromycin and gastric motility: site of action. J Gastrointest Motility, 1993;5:253-263.

8. Hughes S, Behrns KE, Sarr MG. Chronic bile diversion does not alter canine interdigestive myoelectric activity. Dig Dis Sci, 1993;38:1055-1061.

9. Behrns KE, Smith CD, Sarr MG. Prospective evaluation of gastric acid secretion and cobalamin absorption following gastric bypass for clinically severe obesity. Dig Dis Sci, 1994; 39:315-320.

10. Smith CD, Behrns KE, van Heerden JA, Sarr MG. Radical pancreatoduodenostomy for misdiagnosis: lessons learned. Br J Surg, 1994;81:585-589.



11. Behrns KE, Sarr MG. Duodenal nutrients inhibit canine jejunal fasting motor patterns through a hormonal mechanism. Dig Dis Sci, 1994;39:1665-1671.

12. Behrns KE, Sarr MG, Strickler JG. Pancreatic lymphoma: is it a surgical disease? Pancreas, 1994; 9:662-667. 13. Behrns KE, Sarr MG, Hanson RB, Benson JT, Zinsmeister AR. Effect of enteric non-nutrient infusions on motor

patterns in neurally intact and neurally isolated canine jejunum. J Surg Research, 1995;59:405-414. 14. Behrns KE, Sarr MG, Hanson RB, Zinsmeister AR. Neural control of canine small intestinal motility during non-

nutrient infusion. Am J Physiol, 1996;271 (Gastrointest. Liver physiol. 34): G423-G432.

15. Behrns KE, Sarr MG, Hanson RB, Zinsmeister AR. Jejunoileal transplantation. Effects on characteristics of canine jejunal motor activity in vivo. Dig Dis Sci, 1996;41:884-893.

16. Behrns KE, Schlinkert RT. Laparoscopic Management of Paraesophageal Hernia: Early Results. J

Laparoendoscopic Surgery; 1996;6(5):311-317. 17. Behrns KE, Sarr MG, Hanson RB, Zinsmeister AR. Canine small bowel motor patterns and contractions are not

neurally regulated during enteric nutrient infusion. Am J Physiol, May 1998;274 (5 Pt 1):G912-922. 18. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk

factor for major hepatic resection. J Gastrointestinal Surg, 1998;2:292-298. 19. Behrns KE, Koruda MJ, Herbst CA. Gastroesophageal reflux disease: pill, blade, or laparoscope? N C Med J,

1997;58:436-438. 20. Iimuro Y, Nishiura T, Hellerbrand C, Behrns KE, Shoonhoven R, Grisham JW, Brenner DA. NFκß prevents

apoptosis and liver failure during liver regeneration. J Clin Investigation, 1998;101:802-811. 21. Behrns KE, Shaheen NJ, Grimm IS. Type I choledochal cyst in association with familial adenomatous polyposis.

Am J Gastroenterology, 1998;93:1377-1379. 22. Jobin C, Behrns KE, Brenner DA. Molecular and cellular biology of the small intestine. Curr Op in

Gastroenterology, 1999;15:103-107. 23. Behrns KE, Schrum LW, Que F. Apoptosis: Cell Death by Proteolytic Scalpel. Surgery, 1999;126:463-468. 24. Heider TR, Meyer AA, Galanko J, Behrns KE. Percutaneous drainage of pancreatic pseudocysts is associated

with a higher failure rate than surgical treatment. Ann Surg, 1999; 229:781-789. 25. Behrns KE, Kircher A, Brownstein M, Koruda MJ. Prospective, randomized trial of early initiation and hospital

discharge on a liquid diet following elective intestinal surgery. J Gastrointestinal Surgery, 2000;4:217-221. 26. Schrum LW, Rippe RA, Black DM, Brenner DA, Behrns KE. c-Jun does not mediate hepatocyte apoptosis

following NFB inhibition and partial hepatectomy. J Surg Research, 2000;88:142-149. 27. Heider TR, Warshauer DM, Behrns KE. Inverted Meckel’s diverticulum as a source of chronic gastrointestinal

blood loss. Surgery, 2000;128:107-108. 28. Jenkins JT, Taylor AJ, Behrns, KE. Secondary Causes of Intestinal Obstruction: Rigorous Preoperative

Evaluation is Required. Am Surg, 2000;66(7):662-666.



29. Schrum LW, Bird MA, Salcher O, Burchardt ER, Grisham JW, Brenner DA, Rippe RA, Behrns KE. Autocrine expression of activated transforming growth factor-beta (1) induces apoptosis in normal rat liver. Am J Physiology Gastrointest Liver Physiol, 2001;280(1):G139-48.

30. Heider TR, Farrell TM, Kircher AP, Colliver CC, Koruda MJ, Behrns KE. Complete fundoplication is not associated

with increased dysphagia in patients with abnormal esophageal motility. J Gastrointestinal Surg, 2001;5(1):36-41. 31. Heider TR, Behrns KE. Pancreatic pseudocysts complicated by splenic parenchymal involvement: results of

operative and percutaneous management. Pancreas, 2001;23:20-25. 32. Bird MA, Schrum LW, Rippe RA, Behrns KE. Cholestasis induces murine hepatocyte apoptosis and DNA

synthesis with preservation of the immediate – early gene response. Surgery, 2002;131:556-563. 33. Samson CM, Schrum LW, Bird MA, Lange PA, Brenner DA, Rippe RA, Behrns KE. Transforming growth factor-β1

induces hepatocyte apoptosis by a c-Jun independent mechanism. Surgery, 2002;132(3):441-449. 34. Morton JM, Bowers SP, Lucktong TA, Mattar S, Bradshaw WA, Behrns KE, Koruda MJ, Herbst CA, McCartney

W, Halkar RK, Smith CD, Farrell TM. Gallbladder function before and after fundoplication. J Gastrointestinal Surg, 2002;6(6):806-811.

35. Heider TR, Behrns KE, Koruda MJ, Shaheen NJ, Lucktong TA, Bradshaw B, Farrell TM. Fundoplication improves

disordered esophageal motility. J Gastrointestinal Surg, 2003;7:159-163. 36. Poole ME, Bernard SA, Churchel MA, Weissler MC, Calvo B, Cance W, Ollila D, Koruda M, Behrns K, Detterbeck

FC. A Phase I Study of Gencitabine and Docetaxel for Advanced Stage Solid Tumors. Cancer Investigation, 2003;21(3):350-354.

37. Bird MA, Black D, Lange PA, Samson CM, Hayden M, Behrns KE. NFкB Inhibition Decreases Hepatocyte

Proliferation but Does Not Alter Apoptosis in Obstructive Jaundice. J Surg Research, 2003;114(2):110-117. 38. Lange PA, Samson CM, Bird MA, Hayden MA, Behrns KE. Cirrhotic hepatocytes exhibit decreased TGFβ growth

inhibition associated with downregulated Smad protein expression. Biochem and Biophys Res Commun, 2004;313:546-551.

39. Black D, Lyman S, Heider TR, Behrns KE. Molecular and Cellular Features of Hepatic Regeneration. J Surg

Research, 2004;117(2):306-315. 40. Zaré SM, Galanko J, Behrns KE, Koruda MJ, Boyle LM, Farley DR, Evans S RT, Meyer AA, Sheldon GF, Farrell

TF. Psychological well-being of surgery residents before the 80-hour work week: a multi-institutional study. J Am Col Surg, 2004;198(4):633-640.

41. Heider TR, Koruda MJ, Farrell TM, Behrns KE. Acute vagotomy does not augment the systemic inflammatory

response in patients with peptic ulcer disease. Am Surg, 2004;70(4):342-6. 42. Black D, Bird MA, Samson CM, Lyman S, Lange PA, Schrum LW, Qian T, Lemasters JJ, Brenner DA, Rippe RA,

Behrns KE. Primary cirrhotic hepatocytes resist TGF-induced apoptosis through a ROS-dependent mechanism. J Hepatology, 2004;40:942-951.

43. Heider TR, Azeem S, Galanko JA, Behrns KE. The natural history of pancreatitis-induced splenic vein thrombosis.

Ann Surg, 2004;239(6):876-882. 44. Morton JM, Baker C, Farrell T, Yohe M, Kimple RJ, Herman D, Galanko J, Behrns K, Meyer A. What do surgery

residents do on their call nights? Am J Surg, 2004;188(3):225-229.



45. Black D, Bird MA, Hayden M, Schrum LW, Lange P, Samson C, Hatano E, Rippe RA, Brenner DA, Behrns KE.

TNF-induced hepatocyte apoptosis is associated with alterations of the cell cycle and decreased stem loop binding protein. Surgery, 2004;135:619-628.

46. Morton JM, Brown A, Galanko JA, Norton JA, Grimm IS, Behrns KE. A national comparison of surgical versus

percutaneous drainage of pancreatic pseudocysts: 1997-2001. J Gastrointest Surg, 2005;9(1):15-21. 47. Zare SM, Galanko JA, Behrns KE, Sieff EM, Boyle LM, Farley DR, Evans SR, Meyer AA, Farrell TM. Psychologic

well-being of surgery residents after inception of the 80-hour workweek: a multi-institutional study. Surgery 2005;138:150-157.

48. Heider TR, Brown A, Grimm IS, Behrns KE. Endoscopic sphincterotomy permits interval laparoscopic

cholecystectomy in patients with moderately severe gallstone pancreatitis. J Gastrointest Surg 2006;10:1-5. 49. Christie N, Parsons AM, Behrns KE. Metastatic hepatic paraganglioma six years after carotid body tumor

resection. Clinical Gastroenterol Hepatol 2006;4:xxiv. 50. Raval J, Lyman S, Nitta T, Mohuczy D, Lemasters JJ, Kim J-S, Behrns KE. Basal reactive oxygen species

determine the susceptibility to apoptosis in cirrhotic hepatocytes. Free Rad Biol Med 2006;41:1645-1654. 51. Heider TR, Lyman S, Schoonhoven R, Behrns KE. Ski promotes tumor growth through abrogration of

transforming growth factor beta signaling in pancreatic cancer. Ann Surg,2007;246:61-68. 52. Siri J, Reed A, Flynn T, Silver M, Behrns KE. A multi-disciplinary system-based practice learning experience and

its impact on surgical residency education. J Surg Educ, 2007;64:328-332. 53. Behrns KE, Ashley SW, Hunter JG, Carr-Locke D. Early ERCP for gallstone pancreatitis: for whom and when? J

Gastrointest Surg 2008;12:629-633. 54. Black D, Lyman S, Qian T, Lemasters JJ, Rippe RA, Nitta T, Kim J-S, Behrns KE. Transforming growth factor

beta mediates hepatocyte apoptosis through Smad3 generation of reactive oxygen species. Biochimie, 2007;89:1464-1473.

55. Kim J-S, Nitta T, Mohuczy D, O’Malley KA, Moldawer LL, Dunn WA Jr., Behrns KE. Impaired autophagy: a

mechanism of mitochondrial dysfunction in anoxic rat hepatocytes. Hepatology 2008;74:1725-1736. 56. Kim RD, Kim J-S, Watanabe G, Mohuczy D, Behrns, KE. Liver regeneration and the atrophy-hypertrophy

complex. Sem Interventional Rad 2008;25:92-103. 57. Nitta T, Kim J-S, Mohuczy D, Behrns KE. Murine cirrhosis induces hepatocyte epithelial mesenchymal transition

and alterations in survival signaling pathways. Hepatology 2008;48:909-919. 58. Evans KA, Clark CW, Vogel SB, Behrns KE. Surgical management of failed endoscopic treatment of pancreatic

diseases. J Gastrointest Surg 2008;12:1924-1929. 59. Behrns KE. Local resection of the pancreatic head for pancreatic pseudocysts. J Gastrointest Surg, 2008;

12(12):2227-2230.

60. Brown A, Young B, Morton J, Behrns K, Shaheen N. Are health related outcomes in acute pancreatitis improving? An analysis of national trends n the US from 1997 to 2003. JOP 2008;9:408-414.

61. Behrns KE, Ben-David K. Surgical therapy of pancreatic pseudocysts. J Gastrointest Surg, 2008;12:2227-2230.



62. Kim J-S and Behrns KE. Integral role of hepatocytes in cirrhotic liver. US Gastro Hepatol Rev 2009;4:37-39.

63. Warner EA, Ben-David K, Cendan JC, Behrns KE. Laparoscopic Pancreatic Surgery: What Now and What Next?

Curr Gastroenterol Rep 2009;11(2):128-133. DOI 10.1007/s11894-009-0020-8.

64. Watanabe G, Behrns KE, Jim JS, Kim RD. Heat shock protein 90 inhibition abrogates hepatocellular cancer growth through cdc2-mediated G2/M cell cycle arrest and apoptosis. Cancer Chemother Pharmacol 2009;64:433-443.

65. Grobmyer SR, Hunt DL, Forsmark CE, Draganov PV, Behrns KE, Hochwald SN. Pancreatic stent placement is associated with resolution of refractory grade C pancreatic fistula after left-sided pancreatectomy. Am Surg 2009; 75(8):657-7; discussion 657-8.

66. Forsmark, CE, Behrns KE. Autoimmune pancreatitis: making progress step by step. Clin Gastroenterol Hepatol.

2009; 7:1026-1027.

67. Grobmyer SR, Hemming AW, Harris N, Behrns K, Logan H, Kim RD, Chang M, Cance WG, Hochwald SN. A pilot prospective randomized trial of postoperative epoetin alfa in patients undergoing major operation for upper gastrointestinal malignancy. Am J Clin Oncol 2009; Dec; 32(6):570-3.

68. Behrns, KE. Gastric remnant cancer: is elimination of the bug the answer? Arch Surg, 2010; 145(10):967.

69. Behrns KE, Howard TJ. Pancreatic necrosis: when to scope, poke or cut? Gastrointest Endosc 2010; 72(6):1326-7.

70. Hochwald SN, Grobmyer SR, Hemming AW, Curran E, Bloom DA, Delano M, Behrns KE, Copeland EM, Vogel SB. Braun enteroenterostomy is associated with reduced delayed gastric emptying and early resumption of oral feeding following pancreaticduodenectomy. J Surg Oncol 2010; 101(5):351-355.

71. Cuenca AG, Wynn JL, Kelly-Scumpia KM, Scumpia PO, Vila L, Delano MJ, Mathews CE, Wallet SM, Reeves WH, Behrns KE, Nacionales DC, Efron PA, Kunkel SL, Moldawer LL. Critical role for CXC ligand 10/CXC receptor 3 signaling in the murine neonatal response to sepsis. Infect Immun 2011; 79:2746-54.

72. Wang JH, Ahn IS, Fischer TD, Byeon JI, Dunn WA Jr, Behrns KE, Leeuwenburg C, Kim JS. Autophagy suppresses age-dependent ischemia and reperfusion injury in livers of mice. Gastroenterology 2011; 141(6):2188-2199.

73. Wang JH, Behrns KE, Leeuwenburgh C, Kim JS. Critical role of autophage in ischemia/reperfusion injury to aged livers. Autophagy 2012; 8(1):140-141.

74. Behrns KE, Copeland EM III, Howard RJ. The University of Florida Department of Surgery: Building a Stronger Tomorrow on Yesterday’s Foundation. Am Surg 2012; 78(1):12-19.

75. Behrns KE, Ang DN, Liu H, Hughes SJ, Russin M, Creel H, Flynn TC. Faculty Clinical Quality Goals Drive Improvement in University HealthSystem Consortium Outcome Measures. Am Surg 2012; 78(7):749-754.

76. Behrns KE. Hepatobiliary cancer and pyogenic liver abscess: when poking the skunk is not enough: invited commentary on Chen, et al. Am J Surg 2013; 205:52-57.

77. Tepas JJ 3rd, Hughes TG Sr, Aaronson DS, Kesler JL, Buckley RJ, Dippolito AJ, Wall MJ, Merchant NB, Dandridge WC, Sinanan MN, Buchbinder D, Sussman HL, Hayes-Jordan A, Chen JC, Wetstein L, Arbutina DR, Dennehy JC 3rd, Alseidi A, Rege RV, Fink AS, Barney LM, Cloyd DW, Fallat ME, Loeff DS, Behrns KE, Vickers SM. Surgical care and career opportunities in a changing practice paradigm. J Am Coll Surg 2013; 217(4):711-717.



78. Vlada CA, Schmit B, Perry A, Trevino JG, Behrns KE, Hughes SJ. Failure to follow evidence-based best practice guidelines in the treatment of severe acute pancreatitis. HPB 2013; 15(10):822-827.

79. Kim JS, Wang JH, Biel T, Kim DS, Flores-Toro J, Vijayvargiya R, Zendejas I, and Behrns K. Carbamazepine Suppresses Calpain-mediated Autophagy Impairment After Ischemia/Reperfusion In Mouse Livers. Toxicol. Appl. Pharamcol. 2013; 273(3):600-610.

80. Yang D, Behrns KE, Forsmark CE. Images of the Month: A Rare Presentation Of A Pancreatic Neuroendocrine Tumor. Am J Gastroenterol. 2013;108:1694.

81. Cendan J, Wier D, Behrns K. A Primer on Standards Setting as it Applies to Surgical Education and Credentialing.Surg Endosc. 2013; 27(7):2631-2637.

82. Hughes SJ, Neichoy B, Behrns KE. Laparoscopic Intussuscepting Pancreaticojejunostomy. J Gastrointest Surg 2013; 18(1):208-212.

83. Ang DN, Behrns KE. Using a Relational Database to Improve Mortality and Length of Stay for a Department of Surgery: A Comparative Review of 5,200 Patients. Am Surg 2013; 79(7):706-710.

84. Van Buren, George II; Bloomston, Mark; Hughes, Steven J.; Winter, Jordan; Behrman, Stephen W.; Zyromski, Nicholas J.; Vollmer, Charles; Velanovich, Vic; Riall, Taylor; Muscarella, Peter; Trevino, Jose; Nakeeb, Attila; Schmidt, C. Max; Behrns, Kevin; Ellison, E. Christopher; Barakat, Omar; Perry, Kyle A.; Drebin, Jeffrey; House, Michael; Abdel-Misih, Sherif; Silberfein, Eric J.; Goldin, Steven; Brown, Kimberly; Mohammed, Somala; Hodges, Sally E.; McElhany, Amy; Issazadeh, Mehdi; Jo, Eunji; Mo, Qianxing; Fisher, William E. A Randomized Prospective Multicenter Trial of Pancreaticoduodenectomy With and Without Routine Intraperitoneal Drainage. Ann Surg 2014; 259(4):605-612.

85. Delitto D, Vertes-George E, Hughes SJ, Behrns KE, Trevino JG. c-Met signaling in the development of tumorigenesis and chemoresistance: Potential applications in pancreatic cancer. World J Gastroenterol 2014; 20(26):8458-8470.

86. Ben-David K, Behrns K, Hochwald S, Rossidis G, Caban A, Crippen C, Caranosos T, Hughes S, Draganov P, Forsmark C, Chauhan S, Wagh MS, Sarosi G. Esophageal Performation Management Using a Multidisciplinary Minimally Invasive Treatment Algorithm. J Am Col Surg 2014; 218(4):768-774.

87. Sarosi GA, Silver MA, Ben-David K,Behrns KE. Training Outcomes of Preliminary Surgical Residents in a University and Veterans Affairs Surgical Residency. JAMA Surg 2014; 149(11):1127-1132.

88. Crippen CJ, Behrns KE, Chen S, Hughes SJ. The Impact of Inter-Hospital Transfers on Surgical Quality Metrics for Academic Medical Centers. Am Surg 2014; 80:690-695.

89. Fischer TD, Gutman DS, Hughes SJ, Trevino JG, Behrns KE. Disconnected Pancreatic Duct Syndrome: Disease Classification And Management Strategies. J Am Col Surg 2014; 219(4):704-12.

90. Fischer TD, Wang JH, Vlada CA, Kim JS, Behrns KE. Role Of Autophagy In Differential Sensitivity Of Hepatocarcinoma Cells To Sorafenib. World J Hepatol 2014; 6(10):752-758.

91. Cuenca AG, Joiner DN, Gentile LF, Cuenca AL, Wynn JL, Kelly-Scumpia KM, Scumpia PO, Behrns KE, Efron PA, Nacionales D, Lui C, Wallet SM, Reeves WH, Mathews CE, Moldawer LL. TRIF-dependent innate immune activation is critical for survival to neonatal gram-negative sepsis. J Immunol 2015; 194:1169-77.



92. Vlada CA, Kim JS, Behrns KE. Autophagy: Self-Preservation Through Cannibalism Of Proteins And Organelles. Surgery 2015; 157(1):1-5.

93. Delitto D, Pham K, Vlada AC, Sarosi GA, Thomas RM, Behrns KE, Liu C, Hughes SJ, Wallet SM, Trevino JG. Patient-Derived Xenograft Models for Pancreatic Adenocarcinoma Demonstrate Retention of Tumor Morphology through Incorporation of Murine Stromal Elements. Am J Pathology 2015; 185(5):1297-1303.

94. Fischer TD, Gutman DS, Warner EA, Trevino JG, Hughes SJ, Behrns KE. Local Pancreatic Head Resection: the Search for Optimal Indications. Am J Surg 2015; 210(3):417-423.

95. Gutwein LG, Helmig RD, Bahler CD, Ben-David K, Behrns KE. Design and experimental evaluation of an anti-leak feeding tube. J Surg Res. 2015; 195:10-15.

96. Sarr MG, Behrns KE, Warshaw AL. Lancet Commission. Editor’s note. Surgery 2015; 157:833.

97. Delitto D, Black BS, Sorenson HL, Knowlton AE, Thomas RM, Sarosi GA, Moldawer LL, Behrns KE, Liu C, George TJ, Trevino JG, Wallet SM, Hughes SJ. The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival. BMC Cancer. 2015; 15:783.

98. Delitto D, Perez C, Han S, Gonzalo DH, Pham K, Knowlton AE, Graves CL, Behrns KE, Moldawer LL, Thomas RM, Liu C, George TJ Jr, Trevino JG, Wallet SM, Hughes SJ. Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer. Cancer Immunol Immunother. 2015; 64:1553-1563.

99. Han S, Delitto D, Zhang D, Sorenson H, Sarosi G, Thomas R, Behrns K, Wallet S, Trevino J, Hughes S. Primary Outgrowth Cultures are a Reliable Source of Human Pancreatic Stellate Cells. Laboratory Investigation 2015; 95:1331-1340.

100. Delitto D, Zhang D, Han S, Black BS, Knowlton AE, Vlada AC, Sarosi GA, Behrns KE, Thomas RM, Lu X, Liu C, George TJ, Hughes SJ, Wallet SM, Trevino JG. Nicotine reduces survival via augmentation of paracrine HGF-MET signaling in the pancreatic cancer microenvironment . Clin Cancer Res 2016; 22:1787-1799.

101. Go KL, Lee S, Zendejas I, Behrns KE, Kim JS. Mitochondrial Dysfunction and Autophagy in Hepatic Ischemia/Reperfusion Injury. BioMed Res Int, Vol 2015 (2015); Art. ID 183469, 14 pgs doi:10.1155/2015/183469.

102. Biel TG, Lee S, Flores-Toro JA, Dean JW, Go KL, Lee MH, Law BK, Law ME, Dunn WA Jr, Zendejas I, Behrns KE, Kim JS. Sirtuin 1 suppresses mitochondrial dysfunction of ischemic mouse livers in a mitofusin 2-dependent manner. Cell Death Differ. 2016; 23:279-290.

103. Chun SK, Go K, Yang MJ, Zendejas I, Behrns KE, Kim JS. Autophagy in ischemic livers: A critical role of sirtuin 1/Mitofusin 2 axis in autophagy induction. Toxicol Res. 2016; 32:35-46.

104. Klionsky DJ, Behrns KE, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016; 12:1-222.

105. Pham K, Delitto D, Knowlton AE, Hartlage ER, Madhavan R, Gonzalo DH, Thomas RM, Behrns KE, George TJ, Hughes SJ, Wallet SM, Liu C, Trevino JG. Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture. Am J Pathology 2016; doi: 10.1016/j.ajpath.2016.02.009.



106. Delitto D, Black BS, Cunningham HB, Sliesoraitis S, Lu X, Liu C, Sarosi GA, Thomas RM, Trevino JG, Hughes SJ, George TJ, Behrns KE. Standardization of Surgical Care in a High-Volume Center Improves Survival in Resected Pancreatic Head Cancer. Am J Surg 2016;doi:10.1016/j.amjsurg.2016.03.001.

Book Chapters and Reviews: 1. Behrns KE, Dalton RR, van Heerden JA, Sarr MG. Extended lymph node dissection for gastric cancer: is it of

value? Surg Clin North Amer, 1992;72:433-443.

2. Behrns KE, Sarr MG. Anticipating and avoiding postgastrectomy stasis problems. Problems in General Surgery, 1993;10:358-365.

3. Behrns KE, Sarr MG. Diagnosis and management of gastric emptying disorders. Advances in Surgery,

1994;27:223-255.

4. Behrns KE. Book Review - Mayo Clinic Proceedings. Surgical anatomy and technique: a pocket manual, by Skandalakis JE, Skandalakis PN, Skandalakis LJ. Mayo Clinic Proceedings, 1995;70:1022.

5. Behrns KE, Brenner DA. Biochemical and molecular basis of hepatic regeneration. Therapy in Liver Diseases:

The Pathophysiology Basis of Therapy. 1998;197-209.

6. Behrns KE, Rippe RA, Brenner DA. Cellular and molecular basis of hepatic fibrosis and therapeutic implications. Future Trends in Gastroenterology. Pharmacology and Therapeutics. 1998,19-23.

7. Rippe RA, Behrns KE, Brenner DA. Molecular biology for the GI clinician. Textbook of Gastroenterology,

supplement, 2nd edition update. (editors: T Yamada, DH Alpers, C. Owayang, DW Powell, SE Silverstein), J. B. Lippincott Company, Philadelphia, PA, Volume 3 (No. 2), 1998, pp. 1-12.

8. Behrns KE, Sarr MG. Primary pancreatic lymphoma. The Pancreas. (editors: HG Beger, AL Warshaw, MW

Buchler, DL Carr-Locke, JP Neoptolemos, C Russell, MG Sarr). Blackwell Science. 1998, London.

9. Hatano E, Bradham C, Behrns KE, Brenner DA. Novel findings in hepatocyte apoptosis. Falk Symposium, Sept. 1999; 12 pp.

10. Behrns KE, Heider TR, Bonnan PC, Bradley EL III, Foxx-Orenstein AE, Pappas TN. Acute pancreatitis and

pseudocysts: controversies in management. Medical Crossfire 2000;1:18-31.

11. Bird MA, Behrns KE. Open Cholecystojejunostomy for biliary obstruction: operative approach. Operative Techniques in General Surgery, 2000;2(4):287-294.

12. Behrns KE. Venous and Enteral Access. Operative Techniques in General Surgery, Guest Editor, 2001;3:201-

308.

13. Behrns KE. Laparoscopic Cholecystectomy After ERCP? Medscape Surgery, 4(1), April 23, 2002.

14. Behrns KE. Treatment of Cholelithiasis and Choledocholithiasis? Medscape Surgery, 4(1), April 11, 2002.

15. Behrns KE. Laparoscopic Cholecystectomy and Pulmonary Function? Medscape Surgery, 4(1), April 30, 2002.

16. Black DM, Behrns KE. A Scientist Revisits the Atrophy-Hypertrophy Complex: Hepatic Apoptosis and Regeneration. Surg Onc Clin N Am, 2002;11:849-864.



17. Behrns KE. Painless Obstructive Jaundice? Medscape Surgery, 4(1), June 20, 2002.

18. Behrns KE. Management of Pancreatic Acinar Cell Carcinoma? Medscape Surgery, 4(2), July 22, 2002.

19. Behrns KE. Patient Safety: Methods to Assess Risk and Improve Outcomes. i, October, 2002.

20. Rippe RA, Behrns KE, Brenner DA. Molecular Diagnostic Approaches to the Diagnosis of Gastrointestinal Diseases. In Textbook of Gastroenterology, editors, Yamada T, Alpers DH, Laine L, Owyang C, Powell DW. Lippincott, Williams and Wilkins, 4th Edition, Philadelphia, PA, 2003.

21. Behrns KE. Book Review - An Internist’s Illustrated Guide to Gastrointestinal Surgery. Edited by Wu GY, Aziz K,

Whalen GF. Gastroenterology, 2004;126(3):930-931.

22. Behrns KE. Meckel diverticulum: “too” much chatter? Southern Med J, 2004;97(11):1029.

23. Heider TR, Behrns KE. Book Review- Mayo Clinic Gastrointestinal Surgery. Edited by Kelly KA, Sarr MG, Hinder RA. Gastroenterology, 2004;127:1858.

24. France M, Behrns KE. Patient satisfaction after laparoscopic antireflux surgery: community achievement.

Southern Med J, 2005;98:403-404.

25. Sarmiento J, Tsositos G, Murr M, Behrns K, Cunha JE, Nealon WH. Summary of the proceedings of the 38th annual meeting of the pancreas club. J Gastrointest Surg 2005;9:751-756.

26. Cendan JC and Behrns KE. Associated neoplastic disease in inflammatory bowel disease. Surg Clin North Am

2007;87:659-672.

27. Behrns KE. Pancreatic Pseudocysts. Cameron’s Current Surgical Therapy, 9th ed., Mosby/Elsevier, Philadelphia, PA, 2008.

28. Behrns KE, Ashley SW, Hunter JG, Carr-Locke D. Early ERCP for gallstone pancreatitis: for whom and when? J

Gastrointest Surg 2008:12:629-633. Review. 29. Kim JS and Behrns KE. Integral role of Hepatocytes in Cirrhotic Liver. US Gastroenterology & Hepatology

Review. 2008;4(2):37-39.

30. Kim RD, Kim J-S, Behrns KE. Liver Regeneration and the Atrophy-Hypertrophy Complex. In: Venous Embolization of the Liver: Radiologic and Surgical Practice (editors: DC Madoff, M Makuuchi, M Nagino, J-N Vauthey). Springer-Verlag, London; 2011:37-47.

31. Ben-David K, and Behrns KE. Drainage of Pancreatic Pseudocyst. In: Master Techniques in Surgery: Hepatobiliary and Pancreatic Surgery (editors:K Lillemoe, W Jarnagin and J Fischer) Lippincott Williams & Wilkins, Philadelphia, 2013 12:147-159.

32. Ben-David K, Caban AM, Behrns KE. Gastric Resection and Reconstruction. In: Shakelford’s Surgery of the Alimentary Tract, 7th edition (editors: J Peters, D McFadden and C Yeo) Elsevier Saunders, Philadelphia, PA 2013. Vol 1, 58:731-756.

33. Caban A, Behrns KE. Truncal Vagotomy with Antrectomy and Roux-En-Y Reconstruction. In: Master Techniques in Surgery: Gastric Surgery (editors: M Nussbaum and J Fischer) Lippincott Williams & Wilkins, NY, 2013 7:73-88.



34. Loftus TJ, Kresak JL, Gonzalo DH, Sarosi GA Jr., Behrns KE. Duodenal gangliocytic paraganglioma: A case report and literature review. Int J Surg Case Rep. 2015; 8c:5-8.

35. Behrns, KE. Pillar Update: Member Services. In: The Cutting Edge: News and Notes from the Board of Governors; American College of Surgeons. Spring/Summer, 2015.

36. Delitto D and Behrns KE. Gastrointestinal Stromal Tumors. In: Current Controversies in Cancer Care for the Surgeon (editor: K. Morgan) Springer International Publishing, Switzerland, 2016:25-36.

Abstracts 1. Behrns KE, Soper NJ, Sarr MG, Kelly KA, Hughes RW. Anatomic motor and clinical assessment of vertical

banded gastroplasty. Gastroenterology, 94:A611, 1988.

2. Smith CD, Herkes SM, Behrns KE, Fairbanks VF, Sarr MG. Gastric acid secretion and its effects on vitamin B12 absorption after Roux-en-Y gastric bypass. Surg Forum, XLII:171-173, 1991.

3. Hughes SJ, Behrns KE, Sarr MG. Chronic bile diversion from duodenum does not alter canine interdigestive

myoelectric activity. Gastroenterology, 102:A927, 1992.

4. Behrns KE, Sarr MG. Effects of isolated duodenal and isolated jejunoileal infusion of a non-nutrient solution on small intestinal motor patterns. Gastroenterology, 102:A422, 1992.

5. Behrns KE, Sarr MG, Hanson RB, Zinsmeister AR. Effect of isolated duodenal or jejunoileal non-nutrient infusion

on canine enteric single pressure waves (SPWs). Gastroenterology, 104:A475, 1993.

6. Behrns KE, Smith CD, Kelly KA, Sarr MG. Achlorhydria mediates vitamin B12 deficiency after gastric bypass. Gastroenterology, 104:A609, 1993.

7. Behrns KE, Sarr MG, Kelly KA. Reoperative bariatric surgery--lessons learned to improve selection/results: a

prospective study. Gastroenterology, 104:A645, 1993.

8. Nemanich M, Behrns KE, Sarr MG. Motilin, erythromycin, and gastric motility: mechanisms of action. Gastroenterology, 104:A1055, 1993.

9. Behrns KE, Sarr MG, Hanson RB, Zinsmeister AR. Neural mediation of spread of single pressure waves (SPWs)

in the canine jejunum in vivo. Gastroenterology, 106:A465, 1994.

10. Behrns KE, Schlinkert RT. Laparoscopic management of Paraesophageal Hernia: early results. Minimally Invasive Therapy, 4:A13, 1995.

11. Behrns KE, Sarr MG, Hanson RB, Zinsmeister AR. Effect of isolated duodenal and jejunoileal nutrient infusion on

enteric single pressure waves (SPWS). Gastroenterology, 108:A569, 1995.

12. Behrns KE, Sarr MG, Zinsmeister AR. Regulation of enteric single pressure waves (SPWs). Gastroenterology, 110:A631, 1996.

13. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Steatohepatitis as a potential risk

factor for major hepatic resection. Gastroenterology, 112:A1430, 1997.

14. Schrum LW, Iimuro Y, Brenner DA, Behrns KE. Autocrine overexpression of transforming growth factor beta 1 (TGFβ1) does not regulate in vivo hepatic regeneration by inducing apoptosis. Hepatology, 26:266A, 1997.



15. Schrum LW, Black DM, Rippe RA, Iimuro Y, Brenner DA, Behrns KE. c-jun does not mediate hepatocyte

apoptosis following NFκB inhibition and partial hepatectomy. Hepatology, 28:328A, 1998.

16. Schrum LW, Rippe RA, Brenner DA, Behrns KE. Activated transforming growth factor beta 1 (TGFβ1) induces hepatocyte apoptosis in normal liver. Gastroenterology, 116:A1273, 1999.

17. Schrum LW, Samson CM, Rippe RA, Brenner DA, Behrns KE. c-jun is not responsible for TGFβ-1-induced

hepatocyte apoptosis. Gastroenterology, 118:A921, 2000.

18. Heider TR, Farrell TM, Kircher SA, Behrns KE. Complete fundoplication is not associated with increased risk of dysphagia in patients with abnormal esophageal motility. Gastroenterology, A1031, 2000.

19. Schrum LW, Brenner DA, Rippe RA, Behrns KE. NFκB inhibition results in cell cycle arrest prior to TNFα-induced

hepatocyte apoptosis. Hepatology, 32:339A, 2000.

20. Bird MA, Schrum LW, Gross SC, Galanko JA, Brenner DA, Rippe RA, Behrns KE. Primary cirrhotic hepatocytes are more resistant to apoptosis than normal hepatocytes following NFκB inhibition. Hepatology, 32:336A, 2000.

21. Samson CM, Hayden MA, Bird MA, Lange PA, Brenner DA, Behrns KE. Cirrhotic hepatocytes are resistant to

TGFβ1-induced apoptosis in primary murine hepatocytes. Hepatology, 34:270A, 2001.

22. Bird MA, Samson CM, Schrum LW, Lange PA, Hayden MA, Gross SC, Galanko JA, Brenner DA, Rippe RA, Behrns KE. Differential gene expression profiles in primary cirrhotic hepatocytes that exhibit resistance to apoptosis. Hepatology, 34:271A, 2001.

23. Samson CM, Lange PA, Bird MA, Hayden MA, Brenner DA, Behrns KE. Transforming growth factor beta-induced

hepatocyte apoptosis in primary murine hepatocytes is caspase-8 dependent. Gastroenterology, A362, 2001.

24. Bird MA, Amjadi D, Behrns KE. Primary splenic lymphoma complicated by hematemesis and gastric erosion. South Med J, 95(8):941-942, 2002.

25. Black D, Lyman S, Behrns K. Transforming growth factor-β1-induced hepatocyte apoptosis occurs through

Smad3-dependent generation of reactive oxygen species. J Am College of Surgeons (suppl), 195:3, S12, 2002.

26. Morton J, Lucktong T, Behrns K, Koruda M, Farrell T. National trends in fundoplication utilization and outcomes from 1989 and 1999. J Am College of Surgeons (suppl), 195:3, pg S55, 2002.

27. Black D, Schrum L, Lyman S, Behrns K. TNFα-Induced Apoptosis is Associated with Decreased Stem-Loop

Binding Protein. Gastroenterology, 124:A806, 2003.

28. Black D, Lyman S, Qian T, LeMasters JJ, Rippe R, Behrns KE. Transforming Growth Factor Beta 1-Induced Hepatocyte Apoptosis Is Mediated by Smad3-Dependent Acute Generation of Reactive Oxygen Species. Hepatology, 38:4, Suppl. 1, pg 565A, October 2003.

29. Morton J, Brown A, Galanko J, Norton J, Grimm I, Behrns K. A National Comparison of Surgical Versus

Percutaneous Drainage of Pancreatic Pseudocysts: 1997-2001. Gastroenterology, 126:4, Suppl. 2, pg. A768-A769, April 2004.

30. Heider TR, Lyman S, Schoonhoven R, Behrns KE. Ski overexpression impairs TGF-β signaling and results in loss

of growth control in human pancreatic cancer. J Amer College of Surgeons (suppl), 199:3S, pg S20-S21, September 2004.



31. Morton JM, Baker CC, Farrell TM, Yohe ME, Kimple RJ, Herman DC, Udekwu P, Galanko JA, Behrns KE, Meyer AA. What do surgery residents do on their call nights? Am J Surg, 188, pg. 225-229, 2004.

32. Brown A, Dyson T, Grunkmeier DM, James-Stevenson T, Behrns K, Grimm IS. The Panc 4 Score: a Simple,

Inexpensive and Accurate Rule for Early Severity Stratification in Acute Pancreatitis. Gastroenterology, 128:4, Suppl. 2, pg. A172, April 2005.

33. Brown A, Behrns K, Grimm I, Morton J, Shaheen N. Mortality and Incidence Associated with Pancreatic Cancer

are Significantly Decreasing in African Americans (aa) Compared to Other Racial Groups: a Comparison of National Population and Hospital Based Trends from 1992-2002. Gastroenterology, 128:4, Suppl. 2, pg. A558, April 2005.

34. Heider TR, Grimm I, Brown A, Behrns KE. Endoscopic Sphincterotomy Permits Safe Interval Cholecystectomy in

Patients with Moderately Severe Gallstone Pancreatitis. Gastroenterology, 128:4, Suppl. 2, pg. A795, April 2005.

35. Nitta T, Lyman S, Behrns KE. An Activated PI3-Kinase/AKT Pathway Exerts Pro-Survival and Anti-Apoptotic Effects in Primary Mouse Cirrhotic Hepatocytes. Hepatology 2005;42:501A.

36. Nitta T, Mohuczy D, Kim J-S, Behrns KE. Cirrhotic hepatocyte resistance to TGF-mediated apoptosis occurs

through independent up-regulation of PI3K/Akt and MAPK pathways. Hepatology 2006;44: 596A.

37. Kim J-S, Dunn WA, Behrns KE. Impaired autophagy contributes to resistance of cirrhotic liver-derived hepatocytes to transforming growth factor beta (TGFβ) induced apoptosis. Hepatology 2008;48:916A.

38. Watanabe G, Behrns KE, Kim J-S, Kim RD. HSP90 inhibition decreases human hepatocellular cancer xenograft

growth. Hepatology 2008;48:975A. Presentations 1. Behrns KE, et al. Anatomic, motor, and clinical assessment of vertical banded gastroplasty. American

Gastroenterologic Association, New Orleans, Louisiana, May 1988.

2. Behrns KE, et al. Radical pancreatectoduodenectomy for misdiagnosis: lessons learned. Pancreas Club, New Orleans, Louisiana, May 1991.

3. Behrns KE, et al. Effects of duodenal flow on interdigestive patterns of small bowel myoelectric activity. Society of

University Surgeons, Cincinnati, Ohio, February 1992.

4. Behrns KE, et al. Primary pancreatic lymphoma: is it a surgical disease? Pancreas Club, San Francisco, California, May 1992.

5. Behrns KE. et al. Effects of isolated duodenal and isolated jejunoileal infusion of a non-nutrient solution on small

intestinal patterns. American Motility Society, Tahoe City, California, 1992.

6. Behrns KE, et al. Motilin, erythromycin, and the gastric MMC: mechanisms of action. Society of University Surgeons, Seattle, Washington, February 1993.

7. Behrns KE, et al. Reoperative bariatric surgery: lessons learned to improve patient selection and results.

American Gastroenterologic Association, Boston, Massachusetts, May 1993.

8. Behrns KE, et al. Achlorhydria mediates vitamin B12 deficiency after gastric bypass. American Gastroenterologic Association, Boston, Massachusetts, May 1993.



9. Behrns KE, et al. Effect of isolated duodenal or jejunoileal non-nutrient infusions on canine enteric single pressure waves (SPWs). American Gastroenterologic Association, Boston, Massachusetts, May 1993.

10. Behrns, KE, et al. Duodenal nutrients inhibit the canine jejunal fasting motility via a hormonally dependent

mechanism. Association for Academic Surgery, Hershey, Pennsylvania, November 1993.

11. Behrns KE, et al. Neural mediation of spread of single pressure waves in the canine jejunum in vivo. American Gastroenterologic Association, New Orleans, Louisiana, May 1994.

12. Behrns KE, et al. Effect of isolated duodenal and jejunoileal nutrient infusion on enteric single pressure waves

(SPWs). American Gastroenterologic Association, San Diego, California, 1995.

13. Behrns KE, et al. Laparoscopic management of paraesophageal hernia: early results. Society for Minimally Invasive Surgery, Portland, Oregon, September 1995.

14. Behrns KE. A review of interesting surgical cases. Maria Parham Hospital, Henderson, North Carolina, Feb. 1996.

15. Behrns KE. Advances in laparoscopic surgery. Western Wake Medical Center, North Carolina, March 1996.

16. Behrns KE, Sarr MG, Zinsmeister AR. Regulation of enteric single pressure waves (SPWs). American

Gastroenterologic Association, San Francisco, California, May 1996.

17. Behrns KE. Management of acute necrotizing pancreatitis. Grand Rounds, University of Alabama, Tuscaloosa, Alabama, September 1996.

18. Behrns KE. Magnetic resonance cholangiography for choledocholithiasis. Grand Rounds, Wake Medical Center,

Raleigh, North Carolina, January 1997.

19. Behrns KE. MRI cholangiography for choledocholithiasis. New Hanover Regional Medical Center, Wilmington, North Carolina, March 1997.

20. Behrns KE. Chronic abdominal pain. Alamance Regional Medical Center, Burlington, North Carolina, May 1997.

21. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic Steatosis as a potential risk

factor for major hepatic resection. Society of Surgery of the Alimentary Tract, Washington, DC, May 1997.

22. Behrns KE, Iimuro Y, Grisham J, Brenner DA. NFB prevents apoptosis and liver failure during liver regeneration. Gut Hormone Symposium, Florissant, Colorado, July 1997.

23. Behrns KE, Iimuro Y, Nishiura T, Hellerbrand C, Shoonhoven R, Grisham J, Brenner DA. NFB prevents hepatic

failure during liver regeneration. The Association for Academic Surgery, Dallas, Texas, November 1997.

24. Behrns KE, Schrum LW, Iimuro Y, Brenner DA. Autocrine overexpression of transforming growth factor Beta1 (TGF1) does not regulate in vivo hepatic regeneration by inducing apoptosis. American Association for the Study of Liver Diseases, Chicago, Illinois, November 1997.

25. Behrns KE, Isaacs KH. Evaluation of colitis of questionable etiology. University of North Carolina, Chapel Hill,

Medicine Morbidity and Mortality, February 3, 1998.

26. Behrns KE. Autocrine overexpression of transforming growth factor Beta1 does not regulate hepatic regeneration by inducing apoptosis. UNC Center for Gastrointestinal Biology and Disease, Chapel Hill, NC, April 4, 1998.



27. Behrns KE. Laparoscopic Nissen fundoplication and laparoscopic colon resection. AORN Tarheels East OR Nurses meeting, Chapel Hill, North Carolina, April 7, 1998.

28. Behrns KE. Laparoscopic Approach to the GE Junction, Durham, North Carolina. Duke/U.S. Surgical Endoscopy

Center, June 19, 1998.

29. Behrns KE. Laparoscopic management of hiatal hernias. Visiting Professor, New Hanover Regional Medical Center, Wilmington, North Carolina, July 10, 1998.

30. Behrns KE. Laparoscopic surgery of the gastroesophageal junction. North Carolina Chapter of the American

College of Surgeons, Myrtle Beach, South Carolina, July 12, 1998.

31. Behrns KE. Evaluation of the hepatic mass: differential diagnosis. American College of Surgeons Clinical Congress, Orlando, Florida, October 25, 1998.

32. Schrum LW, Black DM, Rippe RA, Iimuro Y, Brenner DA, c-Jun does not mediate apoptosis following NFB

inhibition and partial hepatectomy. American Association for the Study of Liver Diseases. Chicago, Illinois, November 8, 1998.

33. Heider RA, Meyer AA, Galanko J, Behrns KE. Percutaneous drainage of pancreatic pseudocysts is associated

with a higher failure rate than surgical treatment. Southern Surgeons Association. Palm Beach, Florida, December 8, 1998.

34. Behrns KE, Laparoscopic management of paraesophageal hernias. GERD symposium, Ethicon Endosurgery,

Chapel Hill, North Carolina, March 22,1999.

35. Behrns KE. Pancreatic pseudocysts: drain or operate. Grand Rounds, Department of Surgery, UNC, Chapel Hill, North Carolina. April 14, 1999.

36. Behrns KE, Advances in laparoscopy. PACU nurses conference, Chapel Hill, North Carolina. April 24, 1999.

37. Behrns KE. Percutaneous drainage of pancreatic pseudocysts is associated with a higher failure rate than

surgical treatment. Nathan A. Womack Surgical Society, Chapel Hill, North Carolina. May 6, 1999.

38. Behrns KE. Advances in Laparoscopy. AHEC lecture, Smithfield, North Carolina. May 11, 1999.

39. Heider RA, Behrns KE. Management of pancreatic pseudocysts complicated by splenic parenchymal involvement. Pancreas Club, Orlando, Florida. May 16, 1999.

40. Behrns KE, Kircher AS, Brownstein M, Galanko J, Koruda, M. A prospective randomized trial of early initiation

and hospital discharge on a required diet following intestinal surgery. Society of Surgery for the Alimentary Tract, Orlando, Florida. May 17, 1999.

41. Behrns KE. Autocrine overexpression of activated transforming growth factor Beta1 (TGF1) induces apoptosis

following partial hepatectomy. American Gastroenterological Association, Orlando, Florida. May 17, 1999.

42. Behrns KE. Advanced Laparoscopy. Invited Lecturer University of Alabama College of Medicine, Oct. 22, 1999.

43. Behrns KE. Biliary Pancreatitis. Medicine Grand Rounds, Chapel Hill, North Carolina. January 13, 2000.

44. Schrum LW, Brenner DA, Rippe RA, Behrns KE. NFκB inhibition results in cell cycle arrest prior to TNFX – induced hepatocyte apoptosis. American Association for the Study of Liver Disease, Dallas, Texas. Oct. 2000.



45. Bird MA, Schrum LW, Gross SC, Galanko JA, Brenner DA, Rippe RA, Behrns KE. Primary cirrhotic hepatocytes are more resistant to apoptosis than normal hepatocyte following NFκB inhibition. American Association for the study of Liver Disease, Dallas, Texas. October 2000.

46. Bird MA, Schrum LW, Rippe RA, Brenner DA, Behrns KE. Cholestasis induces murine hepatocyte apoptosis and

DNA immediate – early gene response. Association of Academic Surgery, Tampa, Florida. November 2000.

47. Behrns KE. Paraesophageal Hernia: A multidisciplinary approach to complicated esophageal disease & Barrett’s esophagus. Chapel Hill, North Carolina. December 2, 2000.

48. Behrns KE. Concepts in GI Surgery: A case-based management approach. Cystic masses of the liver. Society for

Surgery of the Alimentary Tract, Atlanta, Georgia. May 20, 2001.

49. Behrns KE. Management of chronic pancreatitis. Anesthesiology Grand Rounds, UNC, Chapel Hill, North Carolina. April 24, 2002.

50. Behrns KE. Surgical approaches to pancreatitis. 26th Annual Internal Medicine Conference, Chapel Hill, North

Carolina. April 10, 2002.

51. Behrns KE. Cirrhotic hepatocytes exhibit decreased sensitivity to apoptosis. Priestley Society, 37th Annual Meeting, Monterey, California. October 5, 2002.

52. Behrns KE. Growth control of normal and cirrhotic hepatocytes. Surgical Biology Club II, San Francisco, CA.

October 6, 2002.

53. Behrns KE. Potential Novel Therapies for Pancreatic Cancer. James IV Traveling Fellowship, Hammersmith Hospital, London, United Kingdom. September 4, 2002.

54. Behrns KE. Potential Novel Therapies for Pancreatic Cancer. James IV Traveling Fellowship, Royal Hallamshire

Hospital, Sheffield, United Kingdom. September 10, 2002.

55. Behrns KE. Development of Transgenic Mouse Model of Chronic Pancreatitis. James IV Traveling Fellowship, University of Liverpool, Liverpool, United Kingdom. September 11, 2002.

56. Behrns KE. Growth Control of Normal and Cirrhotic Hepatocytes. James IV Traveling Fellowship, University of

Edinburgh, United Kingdom. September 13, 2002.

57. Behrns KE. Potential Novel Therapies for Pancreatic Cancer. James IV Traveling Fellowship, University of Edinburgh, United Kingdom. September 13, 2002.

58. Behrns KE. Management of Pancreatic Pseudocysts. James IV Traveling Fellowship, Hospital Beaujon, France.

September 17, 2002.

59. Behrns KE. Potential Novel Therapies for Pancreatic Cancer. James IV Traveling Fellowship, Hospital Beaujon, Paris, France. September 17, 2002.

60. Behrns KE. Changes in Surgical Education in the United States. James IV Traveling Fellowship, University of

Heidelberg, Germany. September 19, 2002.

61. Behrns KE. Cirrhotic Hepatocytes Resist Apoptosis. James IV Traveling Fellowship, Kyoto University, Department of Surgery, Tokyo, Japan. December 4, 2002.



62. Behrns KE. Hepatocytes Resist Apoptosis. James IV Traveling Fellowship, Queen Mary Hospital, Hong Kong, China. December 13, 2002.

63. Behrns KE. Potential Novel Therapies for Pancreatic Cancer. James IV Traveling Fellowship, Flinders Medical

Center, Adelaide, Australia. December 16, 2002.

64. Behrns KE. Demystifying Pancreatic Cysts: Pseudocysts. American College of Surgeons 89th Annual Clinical Congress, Lakeside Center, McCormick Place, Chicago, Illinois. October 21, 2003.

65. Heider TR, Azeem S, Behrns KE. The Natural History of Pancreatitis-Induced Splenic Vein Thrombosis. Southern

Surgeons, Homestead, Virginia. December 3, 2003.

66. Behrns KE. Ski Attenuates TGFβ-Induced P21 Expression in Human Pancreatic Cancer. Society of University Surgeons, St. Louis, Missouri. February 12, 2004.

67. Black D, Lyman S, Qian T, LeMasters JJ, Rippe R, Behrns KE. Transforming Growth Factor Beta 1-Induced

Hepatocyte Apoptosis Is Mediated by Smad3-Dependent Acute Generation of Reactive Oxygen Species. 54th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, Massachusetts, October 25, 2003.

68. Heider TR, Behrns KE. Ski overexpression attenuates the induction of p21 by TGF in human pancreatic cancer.

Pancreas Club, New Orleans, Louisiana, May 16, 2004.

69. Morton J, Brown A, Galanko J, Norton J, Grimm I, Behrns K. A National Comparison of Surgical Versus Percutaneous Drainage of Pancreatic Pseudocysts: 1997-2001. Society for Surgery of the Alimentary Tract, New Orleans, Louisiana, May 17, 2004.

70. Pancreas Symposia: Necrotizing Pancreatitis. Invited Faculty, International Hepato-Pancreato-Biliary Association,

Washington, DC, June 3, 2004.

71. Behrns KE. Management of Necrotizing Pancreatitis. Medical Grand Rounds, University of North Carolina at Chapel Hill. September 9, 2004. Chapel Hill, North Carolina.

72. Behrns KE. Cutting Edge: Focus on GI Disorders; GI Laparoscopic Surgeries & Nursing Care. The Friday Center,

Chapel Hill, North Carolina, September 30, 2004.

73. Behrns KE. Chronic Pancreatitis: Old Problem, New Solutions; Pancreatic Pseudocysts: New vs. Old Options. American College of Surgeons 90th Annual Clinical Congress, New Orleans, Louisiana, October 11, 2004.

74. Heider TR, Lyman S, Schoonhoven R, Behrns KE. Ski Overexpression Impairs TGF-β Signaling and Results in

Loss of Growth Control in Human Pancreatic Cancer. American College of Surgeons 90th Annual Clinical Congress, New Orleans, Louisiana, October 13, 2004.

75. Lyman S, Heider TR, Behrns KE. Cirrhotic hepatocyte resistance to TGFβ-induced apoptosis is independent of

the SMAD pathway and upregulation of the nuclear co-repressor, Ski. American Association for the Study of Liver Disease 55th Annual Meeting & Postgraduate Course, Boston, Massachusetts, November 1, 2004.

76. Raval J, Behrns KE. Reactive oxygen species (ROS) state determines hepatocyte transforming growth factor beta

(TGFβ) apoptotic response. Society of University Surgeons Sixty-Sixth Annual Meeting, Nashville, Tennessee, February 11, 2005.



77. Zaré SM, Galanko JA, Behrns KE, Sieff EM, Boyle LM, Farley DR, Evans SR, Meyer AA, Farrell TM. Psychological well-being of surgery residents after inception of the 80-hour work week. Society of University Surgeons Sixty-Sixth Annual Meeting, Nashville, Tennessee, February 11, 2005.

78. Behrns KE. Academic General Surgery: Team Approach to Triple Threat. Grand Rounds, University of California

at Los Angeles, Los Angeles, California, March 9, 2005.

79. Behrns KE. Pancreatic Pseudocysts: Catheter, Scope, or Knife? SSAT Postgraduate Course, Digestive Disease Week, 106th Meeting of the Gastroenterological Association, Chicago, Illinois, May 15, 2005.

80. Brown A, Dyson T, Grunkmeier DM, James-Stevenson T, Behrns K, Grimm IS. The Panc 4 Score: a Simple,

Inexpensive and Accurate Rule for Early Severity Stratification in Acute Pancreatitis. AGA Poster Session, Digestive Disease Week, 106th Meeting of the Gastroenterological Association, Chicago, Illinois, May 15, 2005.

81. Heider TR, Grimm I, Brown A, Behrns KE. Endoscopic Sphincterotomy Permits Safe Interval Cholecystectomy in

Patients with Moderately Severe Gallstone Pancreatitis. SSAT Poster Session, Digestive Disease Week, 106th Meeting of the Gastroenterological Association, Chicago, Illinois, May 16, 2005.

82. Behrns KE. The Making of an Academic Surgeon: Who is Mentoring Whom? Surgery Grand Rounds, Chapel Hill,

North Carolina. June 8, 2005.

83. Nitta T, Lyman S, Behrns KE. An Activated PI3-Kinase/AKT Pathway Exerts Pro-Survival and Anti-Apoptotic Effects in Primary Mouse Cirrhotic Hepatocytes. AASLD, San Francisco, November 14, 2005.

84. Behrns KE. Incidental Pancreatic Cysts: Algorithm for Management. AHPBA Postgraduate Course, Miami Beach,

FL, March 9, 2006.

85. Behrns KE. Current management of pancreatic pseudocysts. American College of Surgeons. Chicago, IL October 9, 2006.

86. Nitta T, Mohuczy D, Kim J-S, Behrns KE. Cirrhotic hepatocyte resistance to TGF-mediated apoptosis occurs

through independent up-regulation of PI3K/Akt and MAPK pathways. AASLD, Boston MA, October 30, 2006.

87. Behrns KE. Surgical leadership in a constrained healthcare climate: forging new frontiers on traditional values. Department of Surgery Grand Rounds, February 28, 2007.

88. Behrns KE. Surgical management of chronic pancreatitis. Gastroenterology Grand Rounds University of Florida.

March 29, 2007.

89. Behrns KE. Pancreatic surgery: state-of-the-art and future directions. Invited international speaker at Faculdade de Ciencias Medicas de Minas Gerais. Belo Horizonte, Brazil, October 18, 2007.

90. Behrns KE. Hepatobiliary diseases: from bench to surgical management. Invited international speaker at

Faculdade de Ciencias Medicas de Minas Gerais. Belo Horizonte, Brazil, October 18, 2007.

91. Behrns KE. Pediatric and geriatric surgery panel discussion. Invited international speaker at Faculdade de Ciencias Medicas de Minas Gerais. Belo Horizonte, Brazil, October 18, 2007.

92. Kim J-S, Nitta T, Mohuczy D, O’Malley KA, Moldawer LL, Dunn WA Jr., Behrns KE. Impaired autophagy: a

mechanism of mitochondrial dysfunction in anoxic rat hepatocytes. AASLD, Boston, MA, November 5, 2007.

93. Wantanabe G, Kim R, Behrns KE. Hsp90 inhibition abrogates hepatocellular cancer growth through cdc2-mediated G2/M cell cycle arrest (Poster). AASLD, Boston MA, November 4, 2007.



94. Behrns KE. The role of chronic inflammation in hepatocyte cell death. Invited seminar speaker- UF & Shands

Cancer Center. Topics in Cancer Cell Biology. Gainesville, FL, March 14, 2008.

95. Behrns KE. The role of chronic inflammation in hepatocyte cell death. Invited seminar speaker-UF Department of Pharmacology & Therapeutics. Gainesville, FL, March 18, 2008.

96. Behrns KE. Academic surgery: team approach to triple threat. Invited seminar speaker- Darmouth Hitchcock

Medical Center. Hanover, FL, April 4, 2008.

97. Evans K, Clark CW, Vogel S, Behrns KE. Surgical management of failed endoscopic treatment of pancreatic disease (poster). SSAT, San Diego, CA, May 21, 2008.

98. Behrns KE. Gallbladder polyps: When to cut out, when to cut bait (invited speaker). Digestive Disease Week, San

Diego, CA, May 21, 2008.

99. Behrns KE. Mayo training as a foundation for an academic career. Priestley Society, Napa, CA, Oct. 10, 2008.

100. Behrns KE. Role of chronic inflammation in hepatocyte cell death. Surgical Biology II Club, San Francisco, CA, October 11, 2008.

101. Kim J-S, Dunn WA, Behrns KE. Impaired autophagy contributes to resistance of cirrhotic liver-derived

hepatocytes to transforming growth factor beta (TGFB) induced apoptosis (poster). AASLD, San Francisco, CA, November 3, 2008.

102. Watanabe G, Behrns KE, Kim J-S, Kim RD. HSP90 inhibition decreases human hepatocellular cancer xenograft

growth (poster). AASLD, San Francisco, CA, November 3, 2008.

103. Validation of a Predictive Algorithm to Maximize Resectability of Pancreatic Adenocarcinoma. Discussant, Ninth American HepatoPancreatoBiliary Congress Annual Meeting, Miami Beach, FL, March 13, 2009.

104. Behrns, KE. Preparing for a Career in Academic Surgery: Hands versus Head. Mayo Clinic Visiting Professor, Rochester, MN, April 6, 2009.

105. Behrns, KE. Postgraduate Course Section: Midgut Emergencies. (Session Chair and Moderator), Society for

Surgery of the Alimentary Tract, 2009 SSAT/AHPBA Joint Symposium, Chicago, IL, May 31, 2009.

106. Behrns, KE. Managing complications of acute pancreatitis: Pancreatic pseudocyst drainage – when, how and most importantly, why? (invited speaker). Society for Surgery of the Alimentary Tract, 2009 SSAT/AHPBA Joint Symposium, Chicago, IL, June 2, 2009.

107. Behrns KE. Management of biliary pancreatitis. Invited presentation. Mercer University, Macon, GA, July 9, 2009.

108. Behrns KE. Current concepts of pancreatic cystic lesions. Invited presentation. Mercer University, Macon, GA, July 10, 2009.

109. Behrns KE. The state of the department of surgery. Department of Surgery Grand Rounds, Gainesville, FL, September 9, 2009.

110. Behrns KE. Early versus delayed pancreatic debridement for infected pancreatic necrosis. Invited presentation. 95th Annual Clinical Congress of the American College of Surgeons, Chicago, IL, October 12, 2009.



111. Behrns KE. Management of biliary pancreatitis. Invited presentation. Fawcett Memorial Hospital Physician CME Program. Invited presentation. Punta Gorda, FL, October 24, 2009.

112. Behrns, KE. The Department of Surgery ~ Where are We? Invited presentation. Woodward Society Spring Meeting, Gainesville, FL, June 18, 2010.

113. Kim J-S, Nitta T, Dunn WA and Behrns, KE. Defective autophagy causes hepatocyte death after ischemia/reperfusion. Poster. FASEB, Liver Growth, Injury & Metabolism – Basic & Applied Biology, Snowmass Village, CO, August 16, 2010.

114. Behrns, KE. The state of the department of surgery. Department of Surgery Grand Rounds, Gainesville, FL, September 1, 2010.

115. Behrns, KE. Autophagy in Chronic Liver Injury: Could it be an Endogenous Mechanism of Repair? Invited presentation. The Halsted Society, Nashville, TN, September 18, 2010

116. Behrns, KE. Management of Complications of Biliary Pancreatitis. Invited presentation. Department of Surgery Grand Rounds, Jacksonville, FL October 13, 2010

117. Behrns, KE. Management of Biliary Pancreatitis. Invited Presentation. Mayo Clinic Surgical Symposium, Wailea, Hawaii, February, 2011

118. Behrns, KE. Cystic Pancreatic Mass: Differential Diagnosis & Treatment. Invited Presentation. Mayo Clinic Surgical Symposium, Wailea, Hawaii, February, 2011

119. Behrns, KE. Surgical Treatment of Chronic Pancreatitis. Invited Presentation. Mayo Clinic Surgical Symposium, Wailea, Hawaii, February, 2011

120. Behrns, KE. Management of Biliary Pancreatitis and its Complications. Invited Presentation. Baylor College of Medicine Grand Rounds, Houston, TX, March 9, 2011.

121. Behrns, KE. The Department of Surgery ~ Where are We? Invited presentation. Woodward Society Spring Meeting, Gainesville, FL, March 18, 2011.

122. Behrns, KE. Management of Complications of Biliary Pancreatitis. Invited presentation. Department of Surgery Grand Rounds, Gainesville, FL, July 27, 2011.

123. Behrns, KE. The state of the department of surgery. Department of Surgery Grand Rounds, Gainesville, FL, September 14, 2011.

124. Behrns, KE. Pancreatic Pseudocysts: Knife, Scope, Drain? Invited presentation. Orlando Health Department of Surgery, Orlando, FL, September 23, 2011.

125. Behrns, KE. Management of Biliary Pancreatitis and its Complications. Invited presentation. University of South Florida Department of Surgery, Tampa, FL. November 7, 2011.

126. Behrns, KE. A Chair’s Experience with a Re-entry Program. Invited presentation. American Board of Surgery annual retreat, Jackson Hole, WY January 8, 2012.

127. Behrns, KE, Ang, DN, Hughes, SJ, Russin, M, Creel, H, and Flynn, TC. Faculty Clinical Quality Goals Drive Improvement in UHC Outcome Measures. Southeastern Surgical Congress, Birmingham, AL, February 13, 2012.



128. Behrns, KE. Pancreatic Surgery 2012 and Beyond: Where Moneyball Meets Pancreatic Surgery. State of the Art Lecture, Invited presentation. Academic Surgical Congress, Las Vegas, NV, February 14, 2012.

129. Behrns, KE. The Department of Surgery ~ Where are We? Invited presentation. Woodward Society Spring Meeting, Gainesville, FL, March 17, 2012.

130. Behrns, KE. A Healthy Dose of Chaos: A Surgeon’s Remedy for Burnout. Invited Presentation. National Women in Surgery Meeting, Baltimore, MD, June 2, 2012.

131. Behrns, KE. The Pancreas/Biliary Surgery Service at the University of Florida. Invited Presentation. Borland Groover Clinic, Jacksonville, FL, July 17, 2012.

132. Behrns, KE. Surgical Management of Complex Pancreatobiliary Diseases. Invited Presentation. Sacred Heart Hospital, Pensacola, FL, September 21, 2012.

133. Behrns, KE. The State of the Department: Chairman’s Address 2012. Department of Surgery Grand Rounds, Gainesville, FL, September 26, 2012.

134. Behrns, KE. Surgical Management of Complex Pancreatobiliary Diseases. Invited Presentation. Health

Management Associates/The Riner Group, Naples, FL October 12, 2012.

135. Behrns, KE. Severe Acute Pancreatitis. Invited Presentation. Southeastern Surgical Congress Postgraduate Course, Jacksonville, FL, February 9, 2013.

136. Behrns, KE. Pseudocyst Historial Perspective: Scalpels not Scopes. Invited Presentation. American HepatoPancreatoBiliary Association Educational Dinner Symposium. February 23, 2013.

137. Behrns, KE. The Department of Surgery ~ Where are We? Invited Presentation. Woodward Society Spring Meeting, Gainesville, FL, March 1, 2013.

138. Behrns, KE. The State of the Department: Chairman’s Address 2013. Department of Surgery Grand Rounds, Gainesville, FL. September 11, 2013.

139. Behrns, KE. Pancreatic Surgery as a Portal to the Future of Academic Surgery. Invited Presentation. University of Wisconsin Grand Rounds Visiting Professor, Madison, WI. November 6, 2013.

140. Behrns, KE. What’s the GIST with GIST? Invited Presentation. Southeastern Surgical Congress Postgraduate Course, Savannah, GA, February 22, 2014.

141. Crippen CJ, Behrns KE, Chen S, Hughes, SJ. Inter-Hospital Transfers Impact Surgical Quality Metrics for Academic Medical Centers. Invited Presentation. Southeastern Surgical Congress, Savannah, GA, February 23, 2014.

142. Behrns, KE. Pancreatic Surgery as a Portal to the Future of Academic Surgery. Invited Presentation. R. Keith Kelly Visiting Professor, Mayo Clinic, Scottsdale, AZ, February 28, 2014.

143. Behrns, KE. The Department of Surgery ~ Where are We? Invited Presentation. Woodward Society Spring Meeting, Gainesville, FL, (via video conference) February 28, 2014.

144. Behrns, KE. Pancreatic Surgery as a Portal to the Future of Academic Surgery. Invited Presentation. Halifax Hospital Grand Rounds, Daytona Beach, FL, May 30, 2014.



145. Behrns, KE. The State of the Department: Chairman’s Address 2014. Department of Surgery Grand Rounds, Gainesville, FL. September 24, 2014.

146. Behrns, KE and McDowell LD. Remodeling a Department. Invited Presentation. Society of Surgical Chairs Annual Meeting, San Francisco, CA. October 26, 2014.

147. Behrns, KE. The State of the Department. Invited Presentation. Woodward Society Spring meeting, Gainesville, FL, February 27, 2015.

148. Behrns, KE. Faculty Engagement of Patients in the Development Process. Invited Presentation. UF Health Development/Department of Surgery Grand Rounds, March 18, 2015.

149. Behrns, KE. Pancreatic Surgery as a Portal to the Future of Academic Surgery. Invited Presentation. Colin G. Thomas Jr. Lecturer, Nathan A. Womack Surgical Society, University of North Carolina, Chapel Hill, NC, May 15, 2015.

150. Behrns, KE. Faculty Engagement of Clients in the Development Process. Invited Presentation. University of Florida College of Veterinary Medicine, Small Animal Clinical Sciences Lecture, June 19, 2015.

151. Behrns, KE. Pancreatic Surgery as a Portal to the Future of Academic Surgery. Invited Presentation. Greenville Health System, Greenville, SC, August 12, 2015.

152. Behrns, KE, The State of the Department 2015: Academic Surgery in 2025. Department of Surgery Grand Rounds, Gainesville, FL. September 23, 2015.

153. Behrns, KE, Patient Presentation CB, Department of Surgery Morbidity & Mortality Conference, Gainesville, FL, February 17, 2016.

154. Behrns, KE, Smith DE, Sweeney JF, Meyers, MO. Invited Presentation. Physician Burnout /Life Balance. Southeastern Surgical Congress Panel Session, Atlanta, GA, February 21, 2016.

155. Behrns, KE. State of the Department 2015-16. Invited Presentation. Woodward Society Spring meeting, Gainesville, FL, February 26, 2016.

156. Behrns, KE. Quality. Invited Presentation. Association of Academic Surgical Administrators. Clearwater, FL, April 8, 2016.

157. Behrns KE Hodin R. Breakfast with the Expert: Writers Workshop Part 2: Submitting and Revising Your Manuscript. Invited Presentation. Digestive Disease Week, San Diego, CA, May 23, 2016.

behrns cv 8-9-16 - university of florida · kevin e. behrns, m.d. august 9, 2016 curriculum vitae...

Documents